Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Avandia (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 16
» View ktuu.com items only
    Dec 4, 2009 | Los Angeles Times

  1. Sulfonylureas for diabetes increase risk of heart disease and death, study finds

    Booster Shots
    Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
    2. Mar 25, 2013 |Story| Los Angeles Times

  2. Girardi | Keese

    Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...

    Tags: Lawyers, Laws, Yaz (drug), Trials, Actos (drug)

    3. Feb 20, 2013 |Story| Baltimore Sun

  3. State AG sues maker of diabetes drugs for false advertising

    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...

    Tags: GlaxoSmithKline PLC, Heart Attack, Chemical Industry, Trials, Litigation

    4. Aug 1, 2012 |Story| Chicago Tribune

  4. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Bipolar Disorder, Chemical Industry, Avapro (drug), HIV, Singulair (drug)

    5. Jul 2, 2012 |Story| WPMT-LTV

  5. Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement

    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history.
    Assistant Press Secretary
    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...

    Tags: Bipolar Disorder, Chemical Industry, Food and Drug Administration, Justice System, Asthma

    6. Jul 2, 2012 |Story| Los Angeles Times

  6. GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...

    Tags: Chemical Industry, Trials, Steve Jobs, Bribery, Prosecution

    7. Feb 7, 2011 |Story| Reuters
  7. |Story

    Tags: Physical Conditions, Chemical Industry, Heart Attack, Politics, Trials

    8. Aug 30, 2007 |Story| Chicago Tribune

  8. Sales stay healthy for Takeda diabetes pill

    About one month after a Food and Drug Administration advisory panel said the diabetes pill Avandia should remain on the market but with strict warnings about heart attack risk, a similar pill sold by a Deerfield-based drugmaker is holding its own in the...

    Tags: Heart Attack, Merck & Company Incorporated, Marketing, Health, Medical Services

    9. Jun 21, 2007 |Story| Chicago Tribune

  9. Diabetes pill's sales health in question

    Heading into this weekend's American Diabetes Association meeting in Chicago, industry analysts are predicting a continued decline of the diabetes pill Avandia. Avandia, sold by British drug giant GlaxoSmithKline PLC, has been losing market share in...

    Tags: Heart Attack, Merck & Company Incorporated, Obesity, GlaxoSmithKline PLC, Finance

    10. Jun 4, 2007 |Story| Los Angeles Times

  10. Diabetics' risk of heart attack

    Special to The Times
    Some 15 million Americans have been diagnosed with Type 2 diabetes mellitus. About 85% take some form of medication or insulin to control it. Recently, scientists reported that one such drug, called Avandia, increased a diabetic's risk of heart attacks by...

    Tags: Heart Attack, Tallahassee (Leon, Florida), Science and Technology, Death, Heart Disease

    11. Jun 29, 2010 |Story| Los Angeles Times

  11. For Diabetes Drug Avandia, Bad News Continues

    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke. The research comes only weeks before an upcoming federal hearing to reconsider its fate.
    Los Angeles Times
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....

    Tags: Heart Attack, Heart Failure, Cleveland Clinic, Trials, Crime, Law and Justice

    12. Jul 13, 2010 |Story| Los Angeles Times

  12. Glaxo Settles Avandia Lawsuits for $460 Million

    GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...

    Tags: Heart Attack, UBS AG, Trials, London (England), Philadelphia (Philadelphia, Pennsylvania)

 1  2 • Next >
Original site for Avandia (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Avandia (drug) Photos
The controversial diabetes drug Avandia will no longer...
(May 19, 2011)
FDA to limit availability of diabetes drug Avandia
6: The FDA said in September that it would sharply limi...
(October 20, 2010)
FDA limits access to Avandia